n Obstetrics and Gynaecology Forum - FDG PET imaging in Gynaecology : guest editorial
|Article Title||FDG PET imaging in Gynaecology : guest editorial|
|© Publisher:||In House Publications|
|Journal||Obstetrics and Gynaecology Forum|
|Publication Date||Jan 2010|
|Pages||37 - 39|
The time has come for the South African medical community to graduate from viewing PET as "Pretty Expensive Technology" or "Promising Emerging Technology". For Positron Emission Tomography (PET) with F-18 fluoro-2-deoxy-D-glucose (FDG) is now the standard of care in initial staging, monitoring the response to therapy, and management of various cancers. This is due to fact that PET is a molecular imaging procedure that allows us to obtain three-dimensional images of what is happening in a patient's body at the molecular and cellular levels. The commonly used radiopharmaceutical, FDG, which is an analogue of glucose, provides qualitative and quantitative metabolic information that is valuable for diagnosis and management of tumors or cancer cells. Of importance, PET is now combined with morphologic information obtained with CT.
Article metrics loading...